HSIC · NMS · Healthcare
Henry Schein, Inc.
Also onShortfallConsensus DriftCrosscheck
Implied value per share
USD 77.55
Market price
USD 86.62
Implied upside
-10.5%
10-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case · Price 2026-11-02 · Accounts to 2025-12-31
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (USD). Outflows negative.
| Line | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 | FY32 | FY33 | FY34 | FY35 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | USD 13.9bn | USD 14.4bn | USD 15.0bn | USD 15.5bn | USD 16.0bn | USD 16.6bn | USD 17.1bn | USD 17.6bn | USD 18.0bn | USD 18.5bn | +3.2% |
| EBIT | USD 835.1m | USD 868.5m | USD 901.6m | USD 934.3m | USD 966.4m | USD 997.8m | USD 1.0bn | USD 1.1bn | USD 1.1bn | USD 1.1bn | +3.2% |
| NOPAT | USD 659.7m | USD 686.1m | USD 712.3m | USD 738.1m | USD 763.5m | USD 788.3m | USD 812.4m | USD 835.8m | USD 858.2m | USD 879.7m | +3.2% |
| Add depreciation & amortisation | USD 262.7m | USD 273.2m | USD 283.6m | USD 293.9m | USD 304.0m | USD 313.9m | USD 323.5m | USD 332.8m | USD 341.8m | USD 350.3m | +3.2% |
| Less capital expenditure | USD -189.0m | USD -208.9m | USD -229.6m | USD -251.2m | USD -273.6m | USD -296.7m | USD -320.4m | USD -344.6m | USD -369.3m | USD -394.3m | +8.5% |
| Capex, % of revenue | 1.4% | 1.4% | 1.5% | 1.6% | 1.7% | 1.8% | 1.9% | 2.0% | 2.0% | 2.1% | - |
| Less increase in working capital | USD -129.2m | USD -105.2m | USD -104.3m | USD -102.9m | USD -101.1m | USD -98.9m | USD -96.2m | USD -93.1m | USD -89.5m | USD -85.5m | -4.5% |
| Free cashflow to firm | USD 604.3m | USD 645.3m | USD 662.0m | USD 677.8m | USD 692.7m | USD 706.6m | USD 719.3m | USD 730.9m | USD 741.1m | USD 750.1m | +2.4% |
| Discount factor | 0.9640 | 0.8959 | 0.8326 | 0.7737 | 0.7191 | 0.6682 | 0.6210 | 0.5771 | 0.5363 | 0.4984 | - |
| Present value | USD 582.5m | USD 578.1m | USD 551.2m | USD 524.5m | USD 498.1m | USD 472.2m | USD 446.7m | USD 421.8m | USD 397.5m | USD 373.9m | - |
| Present Value Of The Forecast | USD 4.8bn | ||||||||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 4.89% | US 10-year Treasury (^TNX), 2026-11-02 |
| Equity risk premium | 4.23% | Damodaran, January 2026 |
| Beta | 0.904 | Reported 0.856, pulled toward 1.0 (Blume) |
| Cost of equity | 8.72% | Risk-free + beta x equity risk premium |
| Cost of debt | 5.67% | Risk-free + 78bp, the spread for a A rating at 5.1x interest cover. Book interest / average debt was lower, at 4.8%. |
| Market capitalisation | USD 9.7bn | 73.7% of capital |
| Total debt | USD 3.4bn | 26.3% of capital, book value as a proxy |
| Tax rate | 21.0% | Effective, capped at statutory |
| WACC | 7.60% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
62% of EV
- Forecast FCFF, final year
- USD 750.1m
- Capex at depreciation, working capital in reinvestment
- USD 1.1bn
- Less reinvestment at g/ROIC (26.1% of NOPAT)
- USD -277.6m
- Capitalised
- USD 786.6m
- ROIC (reported)
- 9.6%
- Terminal value, undiscounted
- USD 15.8bn
- Terminal value, discounted
- USD 7.9bn
- Enterprise value
- USD 12.7bn
- Less net debt
- USD 3.3bn
- Equity value
- USD 9.4bn
Exit at 12.4x EBITDA
65% of EV
- Terminal value, undiscounted
- USD 18.2bn
- Terminal value, discounted
- USD 9.1bn
- Enterprise value
- USD 13.9bn
- Less net debt
- USD 3.3bn
- Equity value
- USD 10.6bn
Spread between methods: 12%.
Sensitivity
Value per share (USD) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 5.60% | 128.06 | 134.58 | 143.60 | 156.53 | 176.17 |
| 6.60% | 97.23 | 99.47 | 102.52 | 106.73 | 112.66 |
| 7.60% | 76.56 | 76.92 | 77.55 | 78.54 | 80.04 |
| 8.60% | 61.75 | 61.22 | 60.76 | 60.41 | 60.17 |
| 9.60% | 50.65 | 49.70 | 48.75 | 47.80 | 46.85 |
Outlined: this model. Green text: above today's price of 86.62. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Actual | Model | Implied | Gap |
|---|---|---|---|---|
| Revenue growth, a year | 1.4% | 3.4% | 4.6% | |
| EBIT margin | 6.9% | 6.0% | 6.6% | |
| Discount rate | - | 7.6% | 7.2% |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.